ClinicalTrials.gg
Not yet recruitingNCT07830745OPTOUpdated Sep 21, 2026

Effects of Optokinetic Stimulation Without a Reading Task in Patients With Hemianopic Alexia

An interventional study of Optokinetic stimulation without reading task and Optokinetic stimulation with reading task in Hemianopia Homonymous and Stroke, sponsored by Clinique Les Trois Soleils. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Clinique Les Trois Soleils · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to investigate whether optokinetic stimulation delivered without a reading task can improve reading performance in adults with post-stroke hemianopic alexia. The main question it aims to answer is: does optokinetic stimulation without a reading task improve reading speed more than optokinetic stimulation with a reading task? Optokinetic stimlation with a reading task is considered the standard rehabilitation. These two conditions will be administered according to a randomized crossover design to determine wether the presence or absence of a reading task influences reading outcomes.

Participants will

  • receive 4 weeks of optokinetic stimulation without a reading task and 4 weeks of optokinétic stimulation with a reading task, with the order of these two interventions determined by randomization,
  • undergo assesments of reading performance, oculomotor behavior, visual field and rehabilitation tolerability before and after each intervention period,
  • undergo a follow-up assesment 1 month after completion of the interventions.
Read the detailed description

Stroke can cause a visual field defect known as homonymous hemianopia (HH). When this visual field loss involves the macula, the central area of vision, it may result in reading difficulties known as hemianopic alexia (HA).

The literature reports improved reading performance in these patients after repeated induction of horizontal optokinetic nystagmus (i.e., an oculomotor reflex consisting of horizontal saccades). To induce this nystagmus, previous studies have used a reading task involving text scrolling from right to left.

However, this type of exercise, which relies on reading, is cognitively demanding and may lead to frustration due to reading difficulties, fatigue, and reduced motivation and potentially the impact of rehabilitation. Therefore, the use of a non-reading task could help overcome these limitations.

The present study aims to compare the efficacy of optokinetic stimulation with reading to optokinetic stimulation without reading in patients with HA.

02

Conditions studied

  • Hemianopia Homonymous
  • Stroke

Keywords

  • Homonymous hemianopia
  • Reading rehabilitation
  • Hemianopic alexia
  • Optokinetic
  • Ocular mobility
03

In context

Hemianopsia

63 studies on the registry are indexed under Hemianopsia; 24 are open to participants now.

This study's planned enrollment of 30 is close to the median of 32 across 53 interventional studies indexed under Hemianopsia.

Browse Hemianopsia studies →

Lead sponsor

Clinique Les Trois Soleils is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Time since lesion > 1 month
  • Diagnosis of homonymous hemianopia post-stroke without macular sparing
  • Reading complaint and/or reading impairment
  • Proficiency in reading French
  • Agreed to give
  • Afiliated with national health insurance

Exclusion criteria

Exclusion Criteria:

  • History of neurological or psychiatric disorders
  • Visual impairment of peripheral origin (i.e., related to damage to the structures of the eye or the optic nerve)
  • Uncorrected visual acuity deficit
  • Reading disorder prior to the stroke (dyslexia)
  • Instability of reading impairment
  • Instability of homonymous hemianopia
  • Major cognitive that would limit the ability of the patient to participate in the study (unilateral spatial neglect, simultanagnosia, comprehension disorder, oral expression disorder)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Other
    Group A

    Patients receive 15 sessions of optokinetic rehabilitation with a reading task, followed by 15 sessions of optokinetic rehabilitation without an associated reading task. The optokinetic rehabilitation sessions with reading are considered the standard of care, while optokinetic rehabilitation without an associated reading task is the experimental condition. Each patient undergoes both conditions sequentially and serves as their own control.

    Other: Optokinetic stimulation without reading task · Other: Optokinetic stimulation with reading task

  • Other
    Group B

    Patients receive 15 sessions of optokinetic rehabilitation without an associated reading task, followed by 15 sessions of optokinetic rehabilitation with a reading task. The optokinetic rehabilitation sessions with reading are considered the standard of care, while optokinetic rehabilitation without an associated reading task is the experimental condition. Each patient undergoes both conditions sequentially and serves as their own control.

    Other: Optokinetic stimulation without reading task · Other: Optokinetic stimulation with reading task

Interventions

  • OtherOptokinetic stimulation without reading task

    Participants are exposed to a horizontally moving optokinetic visual stimulus on a computer screen for 40 minutes per session. The task consists of viewing random sequences of letters scrolling from right to left. The sessions are spread out over 4 weeks, with 3 or 4 sessions per week, to achieve 10 hours (15 sessions) of optokinetic rehabilitation.

  • OtherOptokinetic stimulation with reading task

    Participants are exposed to a horizontally moving optokinetic visual stimulus on a computer screen for 40 minutes per session. The task consists of reading aloud sentences scrolling from right to left. The sessions are spread out over 4 weeks, with 3 or 4 sessions per week, to achieve 10 hours (15 sessions) of optokinetic rehabilitation. The scrolling speed ranges from 85 to 275 words per minute, depending on the participant's reading accuracy.

06

What researchers measure

Primary outcomes

  1. Change in reading speed on paper

    Change in the number of correctly read words per minute, assessed using the International Reading Speed Texts (IReST). For each participant, the change in reading speed will be calculated separately for the optokinetic rehabilitation condition with a reading task and for the optokinetic rehabilitation condition without a reading task. The within-participant changes obtained after each 4-week period will be pooled across the two randomized sequences and compared between conditions. A higher reading speed indicates better reading performance.

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

Secondary outcomes

  1. Change in reading accuracy on paper

    Change in the number and type of errors (paralexias, omissions) assessed using the International Reading Speed Texts (IReST).

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  2. Change in reading speed on screen

    Change in the number of correctly read words per minute, assessed using a screen-based reading task

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  3. Change in reading accuracy on screen

    Change in the number and type of errors (paralexias, omissions), assessed during a screen-based reading task

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  4. Change in subjective reading abilities

    Change in the score on the Hemianopia Reading Questionnaire (HRQ)

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  5. Change in ocular fixations during reading

    Change in the number of fixations and in the mean fixation duration (in ms) during the screen-based reading task, assessed with an eyetracker

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  6. Change in ocular saccades during reading

    Change in the number and in the mean amplitude of saccades (in degrees) during the screen-based reading task, assessed with an eyetracker

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  7. Change in optokinetic nystagmus

    Change of saccade amplitude and frequency during optokinetic stimulation

    Time frame: Baseline and at the end of both rehabilitation: Week 0 and Week 8

  8. Change in visual detection during standard perimetry

    Change in visual sensitivity (in dB) at each tested visual field location on automated static perimetry (Humphrey or Octopus)

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  9. Change in visual detection during screen-based perimetry

    Change in number of correctly detected targets and mean reaction time (in ms) at each tested visual field location on screen-based perimetry

    Time frame: Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  10. Tolerability of rehabilitation

    Score of fatigue, stress, and mood induced by the treatment, self-assessed using a numbered visual analogue scale

    Time frame: Before and after each rehabilitation session

  11. Motivation for rehabilitation

    Score obtained on the Situational Motivation Scale

    Time frame: End of each 4-week rehabilitation period: Week 4 and Week 8

07

Study locations

1 site
08

References and documents

Publications

  • Goodwin D. Homonymous hemianopia: challenges and solutions. Clin Ophthalmol. 2014 Sep 22;8:1919-27. doi: 10.2147/OPTH.S59452. eCollection 2014. PubMed 25284978 ↗
  • Schuett S, Heywood CA, Kentridge RW, Zihl J. Rehabilitation of hemianopic dyslexia: are words necessary for re-learning oculomotor control? Brain. 2008 Dec;131(Pt 12):3156-68. doi: 10.1093/brain/awn285. Epub 2008 Nov 3. PubMed 18984602 ↗
  • Zihl J. Eye movement patterns in hemianopic dyslexia. Brain. 1995 Aug;118 ( Pt 4):891-912. doi: 10.1093/brain/118.4.891. PubMed 7655887 ↗
  • Spitzyna GA, Wise RJ, McDonald SA, Plant GT, Kidd D, Crewes H, Leff AP. Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial. Neurology. 2007 May 29;68(22):1922-30. doi: 10.1212/01.wnl.0000264002.30134.2a. PubMed 17536049 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

Of 36 interventional studies with no phase under Hemianopsia, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 95. This study's planned 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2026
First posted
Sep 21, 2026
StartEst.
Oct 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07830745
Lead sponsor
Clinique Les Trois Soleils
Collaborators
Laboratoire Mémoire Cerveau et Cognition, Boulogne-Billancourt, France
Responsible party
Sponsor
First posted
Sep 21, 2026
Start date
Oct 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Anne-Gaëlle Grosmaire
Contact
ag.grosmaire@les-trois-soleils.fr
+33164715200
Clotilde Guillerot
Contact
c.guillerot@les-trois-soleils.fr
Christophe Duret
principal investigator · Clinique Les Trois Soleils, Boissise-le-Roi, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion